Liver Function Tests: Interpreting ALT, AST, ALP, and GGT

Added:

The Misnomer of LFTs: Why Standard Enzyme Panels Fail to Assess True Liver Function

Critics and advanced hepatologists point out that traditional 'Liver Function Tests' (LFTs)—specifically ALT, AST, ALP, and GGT—are misnamed. Rather than measuring the actual synthetic or metabolic function of the liver, they are merely markers of hepatocyte injury or biliary stasis. Consequently, a patient can have entirely normal enzyme levels despite having advanced, progressive liver disease, such as compensated cirrhosis or non-alcoholic fatty liver disease (NAFLD). An alternative, more comprehensive paradigm emphasizes that true hepatic function should be assessed using actual measures of synthesis (like albumin and prothrombin time/INR) alongside advanced non-invasive staging tools. These include transient elastography (FibroScan) and blood-based algorithmic scores (like the FIB-4 index or APRI) that assess liver fibrosis directly. Furthermore, quantitative liver function tests (such as indocyanine green clearance or methacetin breath tests) offer a more accurate representation of functional hepatic reserve, urging clinicians and students to look beyond static enzyme panels for true clinical assessment.

Basic anatomy and cellular structure of the liver and biliary tract.
Fundamentals of enzyme biochemistry, including cellular localization and how cellular damage leads to enzyme leakage into the blood.
The primary physiological roles of the liver, such as metabolism, detoxification, and bile synthesis.
General principles of clinical pathology and how diagnostic blood tests use reference ranges.
Differentiating between hepatocellular (ALT/AST-dominant) and cholestatic (ALP/GGT-dominant) patterns of liver injury.
Evaluating true hepatic synthetic function using complementary markers like albumin, bilirubin, and prothrombin time (PT/INR).
Clinical diagnostic algorithms for investigating specific etiologies of abnormal LFTs, such as viral hepatitis, NAFLD, and autoimmune liver diseases.
Understanding the diagnostic utility of enzyme ratios, such as the AST/ALT (De Ritis) ratio, in clinical decision-making.
531.4K views7.7Klikes9:19@TachyTutorialsOriginal Release: 2021-03-13

Liver function tests measure ALT (liver-specific), AST (liver and muscle), ALP (biliary and bone), and GGT (biliary-specific) enzymes; elevated ALT indicates hepatocyte damage, elevated AST may indicate muscle or cardiac damage, elevated ALP suggests cholestasis or bone breakdown, and elevated GGT points to biliary issues or alcohol use; key patterns include AST/ALT ratio >2 suggesting alcoholic liver disease and values >1000 IU/L indicating severe conditions like ischemic hepatitis or paracetamol overdose.